Mb, Levis & Associates, LLC Merck & Co., Inc. Transaction History
Mb, Levis & Associates, LLC
- $215 Billion
- Q1 2025
A detailed history of Mb, Levis & Associates, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Mb, Levis & Associates, LLC holds 13,629 shares of MRK stock, worth $1.13 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
13,629
Previous 13,528
0.75%
Holding current value
$1.13 Million
Previous $1.35 Billion
9.1%
% of portfolio
0.57%
Previous 0.67%
Shares
10 transactions
Others Institutions Holding MRK
# of Institutions
3,893Shares Held
1.86BCall Options Held
16.1MPut Options Held
15.1M-
Vanguard Group Inc Valley Forge, PA251MShares$20.8 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$17.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$10 Billion0.49% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.07 Billion0.48% of portfolio
-
Morgan Stanley New York, NY44.2MShares$3.66 Billion0.32% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $210B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...